Calcium dependence of purinergic subtype P2Y 1 receptor modulation of C6 glioma cell migration

Neuroscience Letters

Volumn 497, Issue 2, 2011, Pages 80-84

  Jantaratnotai, Nattinee ^a,b   McLarnon, James G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

2MeSADP; C6 glioma cells; Migration; MRS2179; P2Y 1 receptor; Store operated channel

Indexed keywords

2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; CALCIUM; PURINERGIC P2Y1 RECEPTOR; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID;

ARTICLE; CELL ASSAY; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; GLIOMA CELL; HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPECTROFLUOROMETRY;

ADENOSINE DIPHOSPHATE; ANIMALS; BRAIN NEOPLASMS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM SIGNALING; CELL LINE, TUMOR; CELL MOVEMENT; GLIOMA; INTRACELLULAR FLUID; ION CHANNEL GATING; NEOPLASM INVASIVENESS; PURINERGIC P2Y RECEPTOR AGONISTS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RATS; RECEPTORS, PURINERGIC P2Y1; THIONUCLEOTIDES; TIME FACTORS;

EID: 79956336868     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.04.034     Document Type: Article

References (32)

1. Badie B., Schartner J. Role of microglia in glioma biology. Microsc. Res. Tech. 2001, 54:106-113.
2. Barth R.F., Kaur B. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J. Neurooncol. 2009, 94:299-312.
3. Boyer J.L., Adams M., Ravi R.G., Jacobson K.A., Harden T.K. 2-Chloro N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y(1) receptor antagonist. Br. J. Pharmacol. 2002, 135:2004-2010.
4. Boyer J.L., Mohanram A., Camaioni E., Jacobson K.A., Harden T.K. Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2'-deoxyadenosine 3',5'-bisphosphate. Br. J. Pharmacol. 1998, 124:1-3.
5. Braganhol E., Huppes D., Bernardi A., Wink M.R., Lenz G., Battastini A.M. A comparative study of ectonucleotidase and P2 receptor mRNA profiles in C6 cell line cultures and C6 ex vivo glioma model. Cell Tissue Res. 2009, 335:331-340.
6. Chhatriwala M., Ravi R.G., Patel R.I., Boyer J.L., Jacobson K.A., Harden T.K. Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog. J. Pharmacol. Exp. Ther. 2004, 311:1038-1043.
7. Choi H.B., Hong S.H., Ryu J.K., Kim S.U., McLarnon J.G. Differential activation of subtype purinergic receptors modulates Ca(2+) mobilization and COX-2 in human microglia. Glia 2003, 43:95-103.
8. De Simone R., Niturad C.E., De Nuccio C., Ajmone-Cat M.A., Visentin S., Minghetti L. TGF-beta and LPS modulate ADP-induced migration of microglial cells through P2Y1 and P2Y12 receptor expression. J. Neurochem. 2010, 115:450-459.
9. Hoelzinger D.B., Demuth T., Berens M.E. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J. Natl. Cancer Inst. 2007, 99:1583-1593.
10. Huse J.T., Holland E.C. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat. Rev. Cancer 2010, 10:319-331.
11. Jantaratnotai N., Choi H.B., McLarnon J.G. ATP stimulates chemokine production via a store-operated calcium entry pathway in C6 glioma cells. BMC Cancer 2009, 9:442.
12. Jantaratnotai N., Utaisincharoen P., Piyachaturawat P., Chongthammakun S., Sanvarinda Y. Inhibitory effect of Curcuma comosa on NO production and cytokine expression in LPS-activated microglia. Life Sci. 2006, 78:571-577.
13. Lefranc F., Brotchi J., Kiss R. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J. Clin. Oncol. 2005, 23:2411-2422.
14. Lefranc F., Camby I., Belot N., Bruyneel E., Chaboteaux C., Brotchi J., Mareel M., Salmon I., Kiss R. Gastrin significantly modifies the migratory abilities of experimental glioma cells. Lab. Invest. 2002, 82:1241-1252.
15. Lefranc F., Facchini V., Kiss R. Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist 2007, 12:1395-1403.
16. Lefranc F, Sadeghi N., Metens T., Brotchi J., Salmon I., Kiss R. Characterization of gastrin-induced cytostatic effect on cell proliferation in experimental malignant gliomas. Neurosurgery 2003, 52:881-890,. discussion 890-881.
17. Markovic D.S., Vinnakota K., Chirasani S., Synowitz M., Raguet H., Stock K., Sliwa M., Lehmann S., Kalin R., van Rooijen N., Holmbeck K., Heppner F.L., Kiwit J., Matyash V., Lehnardt S., Kaminska B., Glass R., Kettenmann H. Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:12530-12535.
18. Marteau F., Le Poul E., Communi D., Labouret C., Savi P., Boeynaems J.M., Gonzalez N.S. Pharmacological characterization of the human P2Y13 receptor. Mol. Pharmacol. 2003, 64:104-112.
19. Mason M.J., Mayer B., Hymel L.J. Inhibition of Ca2+ transport pathways in thymic lymphocytes by econazole, miconazole, and SKF 96365. Am. J. Physiol. 1993, 264:C654-662.
20. Mathieu R, Baurand A., Schmitt M., Gachet C., Bourguignon J.J. Synthesis and biological activity of 2-alkylated deoxyadenosine bisphosphate derivatives as P2Y(1) receptor antagonists. Bioorg. Med. Chem. 2004, 12:1769-1779.
21. McLarnon J.G. Purinergic mediated changes in Ca2+ mobilization and functional responses in microglia: effects of low levels of ATP. J. Neurosci. Res. 2005, 81:349-356.
22. McLarnon J.G., Choi H.B., Lue L.F., Walker D.G., Kim S.U. Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients. J. Neurosci. Res. 2005, 81:426-435.
23. Merritt J.E., Armstrong W.P., Benham C.D., Hallam T.J., Jacob R., Jaxa-Chamiec A., Leigh B.K., McCarthy S.A., Moores K.E., Rink T.J. SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem. J. 1990, 271:515-522.
24. North R.A, Surprenant A. Pharmacology of cloned P2X receptors. Annu. Rev. Pharmacol. Toxicol. 2000, 40:563-580.
25. Parsa A.T., Chakrabarti I., Hurley P.T., Chi J.H., Hall J.S., Kaiser M.G., Bruce J.N. Limitations of the C6/Wistar rat intracerebral glioma model: implications for evaluating immunotherapy. Neurosurgery 2000, 47:993-999,. discussion 999-1000.
26. 1 nucleotide receptor-mediated mitogen-activated protein kinase pathways. Circ. Res. 2008, 102:448-456.
27. Stagg J., Smyth M.J. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 2010, 29:5346-5358.
28. Van Meir E.G., Hadjipanayis C.G., Norden A.D., Shu H.K., Wen P.Y., Olson J.J. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J. Clin. 2010, 60:166-193.
29. von Kugelgen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol. Ther. 2006, 110:415-432.
30. Watters J.J., Schartner J.M., Badie B. Microglia function in brain tumors. J. Neurosci. Res. 2005, 81:447-455.
31. Wei W., Ryu J.K., Choi H.B., McLarnon J.G. Expression and function of the P2X(7) receptor in rat C6 glioma cells. Cancer Lett. 2008, 260:79-87.
32. Wen P.Y., Kesari S. Malignant gliomas in adults. N. Engl. J. Med. 2008, 359:492-507.